Stock Titan Trading tools for traders and investors.

-

11:06:43 AM

Last SOLY Stock Market News

SOLY - Soliton Inc

03/04/21 4:05 PM

Nasdaq : SOLY

Soliton Reports Fourth Quarter and Full Year 2020 Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the fourth quarter and full year ended December 31, 2020.Recent Company

RHEA-AI

positive

03/02/21 8:01 AM

Nasdaq : SOLY

Soliton Selects RESONIC(TM) As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that it has selected RESONIC(TM) as the brand name for the Rapid Acoustic Pulse (RAP) Device.The RAP device

RHEA-AI

very positive

02/23/21 8:01 AM

Nasdaq : SOLY

Soliton Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Animal Study

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that a pre-clinical study in animals demonstrated positive results for the potential treatment of

RHEA-AI

neutral

02/22/21 8:01 AM

Nasdaq : SOLY

Soliton to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Thursday,

RHEA-AI

neutral

02/18/21 8:01 AM

Nasdaq : SOLY

Soliton Named Best New Technology Award at the Aesthetic Industry Association Board Meeting

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the company's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the

RHEA-AI

neutral

02/10/21 8:01 AM

Nasdaq : SOLY

Soliton President & CEO Brad Hauser Named as Aesthetic Industry Association Advisory Board Member

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced Brad Hauser, President & CEO of Soliton, has been named as an Aesthetic Industry Association (AIA)

RHEA-AI

neutral

02/01/21 8:01 AM

Nasdaq : SOLY

Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that the U.S. Food and Drug Administration ("FDA") has cleared its Rapid Acoustic Pulse ("RAP")

RHEA-AI

neutral

01/26/21 8:01 AM

Nasdaq : SOLY

Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it has entered into a collaboration with the US Navy to conduct a multi-treatment proof-of-concept clinical

RHEA-AI

neutral

12/30/20 8:01 AM

Nasdaq : SOLY

Soliton Appoints Sean J. Shapiro as Vice President of Sales

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021.Brad Hauser,

RHEA-AI

very positive

11/12/20 7:30 AM

Nasdaq : SOLY

Soliton Reports Third Quarter 2020 Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the third quarter ended September 30, 2020.Third Quarter Company Highlights:Appointed

RHEA-AI

positive